Differential diagnosis of progressive intellectual and neurological deterioration in children.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
03 2021
Historique:
accepted: 25 08 2020
pubmed: 25 9 2020
medline: 25 8 2021
entrez: 24 9 2020
Statut: ppublish

Résumé

To report the differential diagnosis in children with progressive intellectual and neurological deterioration (PIND) in the UK. Since 1997 the PIND Study has searched for variant Creutzfeldt-Jakob disease (vCJD) in children, using the British Paediatric Surveillance Unit to perform prospective surveillance of those younger than 16 years with PIND. From May 1997 to October 2019, 2255 children meeting PIND criteria had been notified, of whom 2008 (1085 males, 923 females) had underlying diagnoses. There were over 220 different diseases, including six cases of vCJD. The numbers presenting in four age groups were: <1 year, 805 (40%); 1 to 4 years inclusive, 825 (41%); 5 to 9 years inclusive, 264 (13%); and 10 to 15 years inclusive, 114 (6%). The two largest ethnic groups were White and Pakistani (58.2% and 17% of diagnosed cases). The most common diseases in these two ethnic groups are shown for the four age groups. The distribution of diseases varied with age but was quite similar in White and Pakistani children. This paper provides a unique guide to the complex differential diagnosis of childhood PIND, showing considerable differences between four age groups, but similarities between ethnic groups. The PIND Study still provides the only systematic surveillance for vCJD in children in the UK. The prevalence of diseases causing childhood progressive intellectual and neurological deterioration in the UK is low (approximately 0.1/1000 live births). There were more than 220 different disorders, mainly genetically determined. The majority of disorders presented early in childhood: 81% before the age of 5 years. There were similarities in the disease spectrum in White and Pakistani children.

Identifiants

pubmed: 32970345
doi: 10.1111/dmcn.14691
pmc: PMC7891454
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-294

Subventions

Organisme : National Institute for Health Research (NIHR) Policy Research Programme
ID : PR- ST-1216-10001

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.

Références

BMC Pediatr. 2007 Jun 27;7:25
pubmed: 17597517
Dev Med Child Neurol. 2010 May;52(5):434-40
pubmed: 19747204
Arch Dis Child. 2010 May;95(5):361-4
pubmed: 19948513
BMC Med Genet. 2009 Dec 26;10:146
pubmed: 20035629
Lancet. 2000 Oct 7;356(9237):1224-7
pubmed: 11072940
Dev Med Child Neurol. 2017 Sep;59(9):965-972
pubmed: 28574146
Arch Dis Child. 2004 Jan;89(1):8-12
pubmed: 14709491
Dev Med Child Neurol. 2016 Jul;58(7):680-9
pubmed: 26866636
Arch Dis Child. 2019 Apr;104(4):360-365
pubmed: 30337492
Dev Med Child Neurol. 2012 Feb;54(2):176-82
pubmed: 22115551
Lancet. 1996 Apr 6;347(9006):921-5
pubmed: 8598754
Rare Dis. 2013 May 30;1:e25212
pubmed: 25003000
Arch Dis Child. 2002 Oct;87(4):269-71
pubmed: 12243988
N Engl J Med. 2017 Jan 19;376(3):292-294
pubmed: 28099827
Vox Sang. 2018 Apr;113(3):220-231
pubmed: 29359329

Auteurs

Christopher Verity (C)

The PIND Research Group, Addenbrooke's Hospital, Cambridge, UK.

Elaine Baker (E)

The PIND Research Group, Addenbrooke's Hospital, Cambridge, UK.

Polly Maunder (P)

The PIND Research Group, Addenbrooke's Hospital, Cambridge, UK.

Suvankar Pal (S)

The National Creutzfeldt-Jakob Disease Research and Surveillance Unit, University of Edinburgh, Edinburgh, UK.

Anne Marie Winstone (AM)

The PIND Research Group, Addenbrooke's Hospital, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH